Vaccine News and Research

Latest Vaccine News and Research

Vaccines and boosters remain strong against current SARS-CoV-2 variants

In a recent study published in the Lancet Microbe journal, Australian researchers studied whether in-vitro neutralization titers could predict vaccine protection from SARS-CoV-2 variants.

17 Nov 2021

Long-term Pfizer vaccine-elicited SARS-CoV-2 antibody profile in breast milk

A new study indicates that the Pfizer vaccine induces antibodies in the breast milk against SARS-CoV-2.

17 Nov 2021

WHO joins global advocates to commemorate Day of Action for Cervical Cancer Elimination

Today WHO joins advocates around the world to commemorate a landmark Day of Action for Cervical Cancer Elimination and welcome groundbreaking new initiatives to end this devastating disease, which claims the lives of over 300 000 women each year.

17 Nov 2021

Study uncovers the herpes virus' strategy for infecting the nervous system

Herpes type 1 is sealed with a kiss for a lifetime. More than half of U.S. adults are carriers of HSV1 (herpes simplex virus type 1) which hibernates in the peripheral nervous system and can never be eradicated.

17 Nov 2021

Experts offers top five holiday travel safety tips for families

With a COVID-19 vaccine authorized by the Food and Drug Administration and recommended by the Centers for Disease Control and Prevention for children ages 5 and up, families may be planning long awaited holiday travel.

17 Nov 2021

Effect of contact networks on SARS-CoV-2 transmission and control

A study demonstrated that the social contacts created in different activity settings affect interventions needed to control outbreaks.

17 Nov 2021

Nationwide Swedish study strengthens evidence for a third booster COVID vaccine dose

A nationwide study from Sweden investigates the effectiveness of COVID-19 vaccination against the risk of symptomatic infection, hospitalization, and death up to 9 months post-vaccination. This study is published on the Preprints with The Lancet website while awaiting peer review.

17 Nov 2021

How effective is the COMIRNATY BNT162b2 vaccine against the SARS-CoV-2 Lambda variant?

Now, researchers from Public Health Services Israel have been investigating a new variant called Lambda to see if it qualifies as a variant of concern. Their research is published in the journal Eurosurveillance.

16 Nov 2021

COVID-19 booster shot extremely beneficial for most cancer patients

Most cancer patients who had no measurable immune response after being fully vaccinated for COVID-19 were helped by a third vaccine dose, according to a new study by investigators at the Montefiore Einstein Cancer Center.

16 Nov 2021

Unprecedented manufacturing strategy provides a template for equitable supply of vaccines

Today, as AstraZeneca reports 2 billion doses of the COVID-19 vaccine released for supply University of Oxford scientists explain how it has been possible to produce so much of the vaccine in less than a year, and the unprecedented strategy used to improve international equity of access.

16 Nov 2021

Wealthier nations should pay COVID-19 vaccine tax to ensure equitable distribution of jabs

Wealthier nations should pay a COVID-19 vaccine tax as part of the price they pay to manufacturers, to ensure a fairer distribution of the jab to poorer nations, argues a political scientist in the Journal of Medical Ethics.

16 Nov 2021

Study: Covid-19 vaccine-elicited immune cells persist six months after vaccination

A recent study by Johns Hopkins Medicine researchers provides evidence that CD4+ T lymphocytes — immune system cells also known as helper T cells — produced by people who received either of the two available messenger RNA (mRNA) vaccines for COVID-19 persist six months after vaccination at only slightly reduced levels from two weeks after vaccination and are at significantly higher levels than for those who are unvaccinated.

16 Nov 2021

Elderly residents of long-term care facilities benefit from booster vaccines against SARS-CoV-2

A recent study investigates whether markers of cellular and humoral immunity differ between adults over 75 and a control group six months after vaccination.

16 Nov 2021

A therapeutic interfering particle for SARS-CoV-2

Researchers report their attempt to engineer TIPs that can conditionally replicate with SARS-CoV-2, inhibit viral replication 10–100 fold, and exhibit R0>1.

16 Nov 2021

More than 13 million people in the UK received COVID-19 booster jabs

More than 13 million life-saving booster jabs have been given across the UK, marking another significant milestone in the phenomenal COVID-19 vaccination programme.

16 Nov 2021

Missouri’s thin dental safety net stretched amid Medicaid expansion

At the Access Family Care clinics in southwestern Missouri, the next available nonemergency dental appointment is next summer. Northwest Health Services, headquartered in St. Joseph, is booked through May. The wait is a little shorter at CareSTL Health in St. Louis — around six weeks.

16 Nov 2021

Vaccine News and Research

Latest Vaccine News and Research

Vaccines and boosters remain strong against current SARS-CoV-2 variants

Long-term Pfizer vaccine-elicited SARS-CoV-2 antibody profile in breast milk

WHO joins global advocates to commemorate Day of Action for Cervical Cancer Elimination

Study uncovers the herpes virus' strategy for infecting the nervous system

Experts offers top five holiday travel safety tips for families

Effect of contact networks on SARS-CoV-2 transmission and control

Nationwide Swedish study strengthens evidence for a third booster COVID vaccine dose

How effective is the COMIRNATY BNT162b2 vaccine against the SARS-CoV-2 Lambda variant?

COVID-19 booster shot extremely beneficial for most cancer patients

Unprecedented manufacturing strategy provides a template for equitable supply of vaccines

Wealthier nations should pay COVID-19 vaccine tax to ensure equitable distribution of jabs

Study: Covid-19 vaccine-elicited immune cells persist six months after vaccination

Elderly residents of long-term care facilities benefit from booster vaccines against SARS-CoV-2

A therapeutic interfering particle for SARS-CoV-2

More than 13 million people in the UK received COVID-19 booster jabs

Missouri’s thin dental safety net stretched amid Medicaid expansion

Modeling the role of antivirals in suppressing the COVID-19 pandemic

Impact of COVID-19 vaccination in the Norwegian population

Myocarditis among Moderna COVID-19 vaccine recipients

Rapid finger stick test to detect antibodies against SARS-CoV-2 variants

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in